Loading…
21st Century Assistive Technology Act
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
84pct
18d open
vs 5,357 other S bills in the 117th — cohort avg 38d
21st Century Assistive Technology Act This bill reauthorizes through FY2026, modifies the funding allocations for, and makes administrative and other changes to programs that increase access to assistive technology devices and assistive technology services for individuals with disabilities. An assistive technology device includes any item, piece of equipment, or system that is used to maintain or improve the functional capabilities of individuals with disabilities (e.g., wheelchairs, hearing aids, or screen readers and computer software), and an assistive technology service is a service that directly assists an individual with a disability with selecting or using such devices, including by evaluating the individual's needs or expanding access to such devices and technology. Specific changes include expanding the scope of certain technical assistance to support grant recipients with data collection, increasing collaboration between agencies that are implementing certain assistive technology grants and state agencies that receive other sources of federal funding for this technology, and adding a more specific focus on older adults in these programs.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (2)
2022 · fourth_quarter · Budget/Appropriations
Issues related to appropriations and user fee funding for the Food and Drug Administration Appropriations - Labor, Health and Human Services, Education, and Related Agencies Issues related to IGNITE America Innovation Act Issues related to HR 1319/S 2401 Rescue America Plan
Client expense: $750,000 · Firm income: Not reported
Placed on Senate Legislative Calendar under General Orders. Calendar No. 121.
Committee on Health, Education, Labor, and Pensions. Reported by Senator Murray with an amendment in the nature of a substitute. Without written report.
Committee on Health, Education, Labor, and Pensions. Ordered to be reported with an amendment in the nature of a substitute favorably.
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Introduced in Senate
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Assistive Technology Act (P.L. 108-364) program funding; 21st Century Assistive Technology Act (S. 2401); Access to assistive technology and devices;
Client expense: $75,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2022 · third_quarter · Health Issues
Issues related to the implementation of PL 115-52, The Food and Drug Administration Reauthorization Act Issues related to the medical supply chain Issues related to implementation of the 21st Century Cures Act Issues related to the competitiveness of the medical technology industry and the impact of Federal Policies Issues related to third party servicing of medical devices Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to coverage and reimbursement of COVID-19 diagnostic tests Issues related to the Valid Act of 2021 - HR 4128/S. 2209 Improving Medical Device Servicing to Protect Patient Safety Act Issues related to the Critical Medical Infrastructure Right-to-Repair Act Issues related to Health Equity Issues related to the PASTEUR Act of 2021 - S. 2076/HR 3932 Issues related to HR 1319/S 2401 Rescue America Plan Issues related to COVID-19 Clinical Testing & Testing Supplies Issues related to Public Health Emergency Preparedness Issues related to PFAS Chemical regulation, H.R. 2457 PFAS Action Act COVID-19 Clinical Testing and Testing Supplies Issues related to consumer and health data privacy Issues related to MDUFA Reauthorization Issues related to PFAS Chemical regulation, H.R. 2457 PFAS Action Act Issues related to HR 7667, Food and Drug Amendments of 2022 Issues related to S. 4348, Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act Issues related to S. 4386, A bill to allow for devices with a predetermined change control plan to be marketed without submitting a supplemental application or premarket notification if the changes to such devices are consistent with such plan. Issues related to S. 3799, PREVENT Pandemics Act
Client expense: $660,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
2022 · third_quarter · Budget/Appropriations
Issues related to appropriations and user fee funding for the Food and Drug Administration Appropriations - Labor, Health and Human Services, Education, and Related Agencies Issues related to IGNITE America Innovation Act Issues related to HR 1319/S 2401 Rescue America Plan
Client expense: $660,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Assistive Technology Act (P.L. 108-364) program funding; 21st Century Assistive Technology Act (S. 2401); Access to assistive technology and devices;
Client expense: $75,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2022 · second_quarter · Health Issues
Issues related to the implementation of PL 115-52, The Food and Drug Administration Reauthorization Act Issues related to the medical supply chain Issues related to implementation of the 21st Century Cures Act Issues related to the competitiveness of the medical technology industry and the impact of Federal Policies Issues related to third party servicing of medical devices Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to coverage and reimbursement of COVID-19 diagnostic tests Issues related to the Valid Act of 2021 - HR 4128/S. 2209 Improving Medical Device Servicing to Protect Patient Safety Act Issues related to the Critical Medical Infrastructure Right-to-Repair Act Issues related to Health Equity Issues related to the PASTEUR Act of 2021 - S. 2076/HR 3932 Issues related to HR 1319/S 2401 Rescue America Plan Issues related to COVID-19 Clinical Testing & Testing Supplies Issues related to Public Health Emergency Preparedness Issues related to PFAS Chemical regulation, H.R. 2457 PFAS Action Act COVID-19 Clinical Testing and Testing Supplies Issues related to consumer and health data privacy Issues related to MDUFA Reauthorization Issues related to PFAS Chemical regulation, H.R. 2457 PFAS Action Act Issues related to HR 7667, Food and Drug Amendments of 2022 Issues related to S. 4348, Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act Issues related to S. 4386, A bill to allow for devices with a predetermined change control plan to be marketed without submitting a supplemental application or premarket notification if the changes to such devices are consistent with such plan. Issues related to S. 3799, PREVENT Pandemics Act
Client expense: $610,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
2022 · second_quarter · Budget/Appropriations
Issues related to appropriations and user fee funding for the Food and Drug Administration Appropriations - Labor, Health and Human Services, Education, and Related Agencies Issues related to IGNITE America Innovation Act Issues related to HR 1319/S 2401 Rescue America Plan
Client expense: $610,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Assistive Technology Act (P.L. 108-364) program funding; 21st Century Assistive Technology Act (S. 2401); Access to assistive technology and devices;
Client expense: $45,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2022 · first_quarter · Budget/Appropriations
Issues related to appropriations and user fee funding for the Food and Drug Administration Appropriations - Labor, Health and Human Services, Education, and Related Agencies Issues related to IGNITE America Innovation Act Issues related to HR 1319/S 2401 Rescue America Plan
Client expense: $790,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · first_quarter · Health Issues
Issues related to the implementation of PL 115-52, The Food and Drug Administration Reauthorization Act Issues related to the medical supply chain Issues related to implementation of the 21st Century Cures Act Issues related to the competitiveness of the medical technology industry and the impact of Federal Policies. Issues related to third party servicing of medical devices Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to coverage and reimbursement of COVID-19 diagnostic tests. Issues related to the Valid Act of 2021 - HR 4128/S. 2209 Implementation of Laboratory Access for Beneficiaries (LAB) Act Improving Medical Device Servicing to Protect Patient Safety Act Issues related to the Critical Medical Infrastructure Right-to-Repair Act Issues related to Health Equity Issues related to the PASTEUR Act of 2021 - S. 2076/HR 3932 Issues related to HR 1319/S 2401 Rescue America Plan Issues related to COVID-19 Clinical Testing & Testing Supplies Issues related to Public Health Emergency Preparedness Issues related to PFAS Chemical regulation, H.R. 2457 PFAS Action Act COVID-19 Clinical Testing and Testing Supplies Issues related to consumer and health data privacy Issues related to MDUFA Reauthorization
Client expense: $790,000 · Firm income: Not reported
2021 · fourth_quarter · Health Issues
Issues related to the implementation of PL 115-52, The Food and Drug Administration Reauthorization Act Issues related to the medical supply chain Issues related to implementation of the 21st Century Cures Act Issues related to the competitiveness of the medical technology industry and the impact of Federal Policies. Issues related to third party servicing of medical devices Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to coverage and reimbursement of COVID-19 diagnostic tests. Issues related to the Valid Act of 2021 - HR 4128/S. 2209 Implementation of Laboratory Access for Beneficiaries (LAB) Act Improving Medical Device Servicing to Protect Patient Safety Act Issues related to the Critical Medical Infrastructure Right-to-Repair Act Issues related to Health Equity Issues related to the PASTEUR Act of 2021 - S. 2076/HR 3932 Issues related to HR 1319/S 2401 Rescue America Plan Issues related to COVID-19 Clinical Testing & Testing Supplies Issues related to Public Health Emergency Preparedness Issues related to PFAS Chemical regulation, H.R. 2457 PFAS Action Act COVID-19 Clinical Testing and Testing Supplies Issues related to consumer and health data privacy
Client expense: $610,000 · Firm income: Not reported
2021 · third_quarter · Health Issues
Issues related to the implementation of PL 115-52, The Food and Drug Administration Reauthorization Act Issues related to the medical supply chain Issues related to implementation of the 21st Century Cures Act Issues related to the competitiveness of the medical technology industry and the impact of Federal Policies. Issues related to third party servicing of medical devices Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to coverage and reimbursement of COVID-19 diagnostic tests. Issues related to the Valid Act of 2021 - HR 4128/S. 2209 Implementation of Laboratory Access for Beneficiaries (LAB) Act Improving Medical Device Servicing to Protect Patient Safety Act Issues related to the Critical Medical Infrastructure Right-to-Repair Act Issues related to Health Equity Issues related to the PASTEUR Act of 2021 - S. 2076/HR 3932 Issues related to HR 1319/S 2401 Rescue America Plan Issues related to COVID-19 Clinical Testing & Testing Supplies Issues related to Public Health Emergency Preparedness
Client expense: $570,000 · Firm income: Not reported
2021 · second_quarter · Health Issues
Issues related to the implementation of PL 115-52, The Food and Drug Administration Reauthorization Act Issues related to the medical supply chain Issues related to implementation of the 21st Century Cures Act Issues related to the competitiveness of the medical technology industry and the impact of Federal Policies. Issues related to third party servicing of medical devices Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to coverage and reimbursement of COVID-19 diagnostic tests. Issues related to the Valid Act of 2020. Implementation of Laboratory Access for Beneficiaries (LAB) Act Improving Medical Device Servicing to Protect Patient Safety Act Issues related to the Critical Medical Infrastructure Right-to-Repair Act Issues related to Health Equity Issues related to the PASTEUR Act Issues related to HR 1319/S 2401 Rescue America Plan Issues related to COVID-19 Clinical Testing & Testing Supplies Issues related to Public Health Emergency Preparedness
Client expense: $550,000 · Firm income: Not reported
2021 · second_quarter · Budget/Appropriations
Issues related to appropriations and user fee funding for the Food and Drug Administration FY2021 Appropriations - Labor, Health and Human Services, Education, and Related Agencies Issues related to HR 1319/S 2401 Rescue America Plan Issues related to IGNITE America Innovation Act
Client expense: $550,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Security Council (NSC), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR), White House Office
2021 · first_quarter · Health Issues
Issues related to the implementation of PL 115-52, The Food and Drug Administration Reauthorization Act Issues related to the medical supply chain Issues related to implementation of the 21st Century Cures Act Issues related to the competitiveness of the medical technology industry and the impact of Federal Policies. Issues related to third party servicing of medical devices Issues related to diagnostics regulation Issues related to promoting innovation in the med tech industry and improving FDA regulatory processes and procedures for devices Issues related to medical technology and the opioid crisis Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to the implementation of H.R.5997 - The Emergency Response Coordinator Act of 2020 Issues related to the implementation of H.R.748 - CARES Act Issues relating to Paycheck Protection Program and Health Care Enhancement Act Issues related to coverage and reimbursement of COVID-19 diagnostic tests. Issues related to the Valid Act of 2020. Implementation of Laboratory Access for Beneficiaries (LAB) Act Improving Medical Device Servicing to Protect Patient Safety Act Issues related to the Critical Medical Infrastructure Right-to-Repair Act Issues related to Health Equity Issues related CBC Health Braintrust Clinical Trials Issues related to the PASTEUR Act Issues related to HR 1319/S 2401 Rescue America Plan
Client expense: $540,000 · Firm income: Not reported
2021 · first_quarter · Budget/Appropriations
Issues related to appropriations and user fee funding for the Food and Drug Administration FY2021 Appropriations - Labor, Health and Human Services, Education, and Related Agencies FY2021 Appropriations for CDC and BARDA Issues related to HR 1319/S 2401 Rescue America Plan Issues related to IGNITE America Innovation Act
Client expense: $540,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Environmental Protection Agency (EPA), Federal Emergency Management Agency (FEMA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR), White House Office
| Republican |
| ME |
Government targets: Centers For Disease Control & Prevention (CDC), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Security Council (NSC), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR), White House Office
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Security Council (NSC), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR), White House Office
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Security Council (NSC), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR), White House Office
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Environmental Protection Agency (EPA), Federal Emergency Management Agency (FEMA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR), White House Office